AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (hGH), specifically designed to focus on lipolytic (fat-burning) activity without affecting insulin levels or IGF-1. Researchers have studied AOD-9604 for its potential role in fat metabolism, cellular function, and tissue repair in preclinical models.
Oral sublingual administration has been explored as a potential alternative to injectable delivery due to its ability to:
Studies suggest that peptides like AOD-9604 may retain their structural integrity when administered sublingually, allowing for efficient uptake into circulation.
AOD-9604 has been studied for its potential to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation). Preclinical research suggests it may have applications in:
✔ Fat Metabolism & Energy Regulation – Investigated for its ability to influence fat breakdown via β3-adrenergic receptor activation.
✔ Cartilage & Joint Repair Studies – Some studies indicate potential effects on cellular repair mechanisms.
✔ Anti-Inflammatory Research – Examined for its possible role in reducing inflammatory markers and oxidative stress.
✔ Metabolic Function & Obesity Research – Studied for its ability to modulate adipose tissue metabolism.
Unlike traditional growth hormone (GH), AOD-9604 has been shown in research to lack insulin-modulating or growth-promoting activity, making it a unique focus for fat metabolism studies.
AOD-9604 is for research purposes only. It is not for human consumption, medical use, or diagnostic applications. All information is provided for scientific and educational research.
LP10 FOR 10% OFF YOUR ORDER | CHECK OUR SALE SECTION FOR DAILY & WEEKLY SALES!!